Synthesis and Biological Evaluation Studies of Novel Quinazolinone Derivatives As Antibacterial and Anti-inflammatory Agents

Overview

Journal Saudi Pharm J

Specialty Pharmacy

Date 2014 Mar 21

PMID 24648828

Citations 9

Authors

Mohamed F Zayed

Memy H Hassan

Affiliations

Soon will be listed here.

Abstract

Some novel 6,8-diiodo-2-methyl-3-substituted-quinazolin-4(3H)-ones bearing sulfonamide derivatives (4-11) were synthesized in good yields and evaluated for their possible antibacterial, anti-inflammatory activities and acute toxicity. The structures of the synthesized compounds were confirmed on the basis of their spectral data and elemental analysis. Their antibacterial activities were evaluated by the agar well diffusion method while their anti-inflammatory activities were evaluated by the carrageenan-induced hind paw edema test. All the tested compounds showed considerable antibacterial activities and high to moderate anti-inflammatory activities that last for 12 h compared to ibuprofen. All the tested compounds showed no toxic symptoms or mortality rates 24 h post-administration at tested anti-inflammatory doses. In addition, LD50 for all tested compounds was higher than that for ibuprofen implying their good safety margin. The obtained results showed that the most active compounds could be useful as a template for future design, modification and investigation to produce more active analogs.

Citing Articles

Synthetic Approaches to Novel DPP-IV Inhibitors-A Literature Review.

Petrov V, Aleksandrova T, Pashev A Molecules. 2025; 30(5).

PMID: 40076268 PMC: 11902039. DOI: 10.3390/molecules30051043.

Quinazoline sulfonamide derivatives targeting MicroRNA-34a/MDM4/p53 apoptotic axis with radiosensitizing activity.

Soliman A, Kodous A, Al-Sherif D, Ghorab M Future Med Chem. 2024; 16(10):929-948.

PMID: 38661115 PMC: 11221547. DOI: 10.4155/fmc-2023-0342.

Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones.

Hashemi A, Noori M, Dastyafteh N, Sadat-Ebrahimi S, Fazelzadeh Haghighi N, Mehrpour K BMC Chem. 2023; 17(1):65.

PMID: 37353836 PMC: 10290372. DOI: 10.1186/s13065-023-00978-3.

Antioxidant and Cytotoxic Activity of New Polyphenolic Derivatives of Quinazolin-4(3H)-one: Synthesis and In Vitro Activities Evaluation.

Pele R, Marc G, Ionut I, Nastasa C, Fizesan I, Pirnau A Pharmaceutics. 2023; 15(1).

PMID: 36678764 PMC: 9867241. DOI: 10.3390/pharmaceutics15010136.

Antiproliferative Activity of a New Quinazolin-4(3)-One Derivative via Targeting Aurora Kinase A in Non-Small Cell Lung Cancer.

Lee J, Yang H, Kim D, Kyaw K, Hu R, Fan Y Pharmaceuticals (Basel). 2022; 15(6).

PMID: 35745617 PMC: 9228987. DOI: 10.3390/ph15060698.

References

Panneerselvam P, Rather B, Ravi Sankar Reddy D, Ramesh Kumar N . Synthesis and anti-microbial screening of some Schiff bases of 3-amino-6,8-dibromo-2-phenylquinazolin-4(3H)-ones. Eur J Med Chem. 2008; 44(5):2328-33. DOI: 10.1016/j.ejmech.2008.04.010. View

Amin K, Kamel M, Anwar M, Khedr M, Syam Y . Synthesis, biological evaluation and molecular docking of novel series of spiro [(2H,3H) quinazoline-2,1'- cyclohexan]-4(1H)- one derivatives as anti-inflammatory and analgesic agents. Eur J Med Chem. 2010; 45(6):2117-31. DOI: 10.1016/j.ejmech.2009.12.078. View

WINTER C, RISLEY E, NUSS G . Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med. 1962; 111:544-7. DOI: 10.3181/00379727-111-27849. View

Giri R, Thaker H, Giordano T, Williams J, Rogers D, Vasu K . Design, synthesis and evaluation of novel 2-thiophen-5-yl-3H-quinazolin-4-one analogues as inhibitors of transcription factors NF-kappaB and AP-1 mediated transcriptional activation: Their possible utilization as anti-inflammatory and anti-cancer.... Bioorg Med Chem. 2010; 18(7):2796-808. DOI: 10.1016/j.bmc.2010.01.007. View

Aly M, Mohamed Y, El-Bayouki K, Basyouni W, Abbas S . Synthesis of some new 4(3H)-quinazolinone-2-carboxaldehyde thiosemicarbazones and their metal complexes and a study on their anticonvulsant, analgesic, cytotoxic and antimicrobial activities - part-1. Eur J Med Chem. 2010; 45(8):3365-73. DOI: 10.1016/j.ejmech.2010.04.020. View

Abbas S, Awadallah F, Ibrahin N, Said E, Kamel G . New quinazolinone-pyrimidine hybrids: synthesis, anti-inflammatory, and ulcerogenicity studies. Eur J Med Chem. 2012; 53:141-9. DOI: 10.1016/j.ejmech.2012.03.050. View

Gassani B, Rezende R, Paiva-Lima P, Ferreira-Alves D, Dos Reis W, Bakhle Y . Is the sulphonamide radical in the celecoxib molecule essential for its analgesic activity?. Pharmacol Res. 2010; 62(5):439-43. DOI: 10.1016/j.phrs.2010.06.007. View

Iemura R, Hori M, Saito T, Ohtaka H . Bioisosteric transformation of H1-antihistaminic benzimidazole derivatives. Chem Pharm Bull (Tokyo). 1989; 37(10):2723-6. DOI: 10.1248/cpb.37.2723. View

Jaiswal M, Khadikar P, Supuran C . Topological modeling of lipophilicity, diuretic activity, and carbonic inhibition activity of benzene sulfonamides: a molecular connectivity approach. Bioorg Med Chem Lett. 2004; 14(22):5661-6. DOI: 10.1016/j.bmcl.2004.08.051. View

10.

Wang Y, Mathis C, Huang G, Debnath M, Holt D, Shao L . Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives. J Mol Neurosci. 2003; 20(3):255-60. DOI: 10.1385/JMN:20:3:255. View

11.

Tiwari A, Mishra A, Bajpai A, Mishra P, Sharma R, Pandey V . Synthesis and pharmacological study of novel pyrido-quinazolone analogues as anti-fungal, antibacterial, and anticancer agents. Bioorg Med Chem Lett. 2006; 16(17):4581-5. DOI: 10.1016/j.bmcl.2006.06.015. View

12.

Liu J, Wilson C, Ye P, Sprague K, Sargent K, Si Y . Privileged structure-based quinazolinone natural product-templated libraries: identification of novel tubulin polymerization inhibitors. Bioorg Med Chem Lett. 2005; 16(3):686-90. DOI: 10.1016/j.bmcl.2005.10.022. View

13.

Dinakaran M, Selvam P, DeClercq E, Sridhar S . Synthesis, antiviral and cytotoxic activity of 6-bromo-2,3-disubstituted-4(3H)-quinazolinones. Biol Pharm Bull. 2003; 26(9):1278-82. DOI: 10.1248/bpb.26.1278. View

14.

Grover G, Kini S . Synthesis and evaluation of new quinazolone derivatives of nalidixic acid as potential antibacterial and antifungal agents. Eur J Med Chem. 2005; 41(2):256-62. DOI: 10.1016/j.ejmech.2005.09.002. View

15.

Skold O . Sulfonamide resistance: mechanisms and trends. Drug Resist Updat. 2001; 3(3):155-160. DOI: 10.1054/drup.2000.0146. View

16.

Huerre M, Gounon P . Inflammation: patterns and new concepts. Res Immunol. 1996; 147(7):417-34. PMC: 7173249. DOI: 10.1016/s0923-2494(97)84407-0. View

17.

Upmanyu N, Gupta J, Shah K, Mishra P . Anti-inflammatory and antinociceptive evaluation of newly synthesized 4-(substituted ethanoyl) amino-3-mercapto-5-(4-methoxy) phenyl-1,2,4-triazoles. J Pharm Bioallied Sci. 2011; 3(2):259-65. PMC: 3103922. DOI: 10.4103/0975-7406.80783. View

18.

Ram V, Farhanullah , Tripathi B, Srivastava A . Synthesis and antihyperglycemic activity of suitably functionalized 3H-quinazolin-4-ones. Bioorg Med Chem. 2003; 11(11):2439-44. DOI: 10.1016/s0968-0896(03)00142-1. View

19.

Sy M, Kitazawa M, Medeiros R, Whitman L, Cheng D, Lane T . Inflammation induced by infection potentiates tau pathological features in transgenic mice. Am J Pathol. 2011; 178(6):2811-22. PMC: 3124234. DOI: 10.1016/j.ajpath.2011.02.012. View

20.

Bot M, Carney R, Freedland K, Rubin E, Rich M, Steinmeyer B . Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression. J Psychosom Res. 2011; 71(1):13-7. PMC: 3115530. DOI: 10.1016/j.jpsychores.2010.11.006. View